comparative-effectiveness research

News
Comparative Effectiveness of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice
09/03/2020
09/03/2020
Journal of Clinical Pathways
Research in Review
High-Dose Treatment for Acute Lymphoblastic Leukemia Safe, Improves Survival
04/29/2016
JCP Editors
Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...
Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...
...
04/29/2016
Journal of Clinical Pathways
Research in Review
Neratinib Delays Recurrence With Fewer Metastases in Patients With Breast Cancer
04/29/2016
JCP Editors
Results from a phase 2 clinical trial showed that combination neratinib and paclitaxel treatment better managed central nervous system progression versus trastuzumab and paclitaxel in patients with ERBB2-positive...
Results from a phase 2 clinical trial showed that combination neratinib and paclitaxel treatment better managed central nervous system progression versus trastuzumab and paclitaxel in patients with ERBB2-positive...
...
04/29/2016
Journal of Clinical Pathways
Research in Review
Standard Therapy Only Used in Half of US Patients With Rectal Cancer
04/20/2016
JCP Editors
Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent...
Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent...
...
04/20/2016
Journal of Clinical Pathways
Research in Review
Enzalutamide Improves Survival Over Bicalutamide in Castration-Resistant Prostate Cancer
02/02/2016
JCP Editors
Treatment with enzalutamide rather than bicalutamide for nonmetastatic or metastatic castration-resistant prostate cancer (CRPC) improves survival, according to results of a phase 2 clinical trial. CRPC occurs when...
Treatment with enzalutamide rather than bicalutamide for nonmetastatic or metastatic castration-resistant prostate cancer (CRPC) improves survival, according to results of a phase 2 clinical trial. CRPC occurs when...
...
02/02/2016
Journal of Clinical Pathways
Viewpoint
Overcoming the Political and Economic Roadblocks Stopping Effective Comparative Drug Evaluation
12/14/2015
Transparent comparative evaluations are necessary for determining the relative value of drugs. But, in part because of the resistance of drug companies and payers, stakeholders are finding other tools to help...
Transparent comparative evaluations are necessary for determining the relative value of drugs. But, in part because of the resistance of drug companies and payers, stakeholders are finding other tools to help...
...
12/14/2015
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use